CSPG4
Sign in to saveAlso known as HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2, chondroitin sulfate proteoglycan 4, CSPG4A
Chondroitin sulfate proteoglycan 4, also known as melanoma-associated chondroitin sulfate proteoglycan (MCSP) or neuron-glial antigen 2 (NG2), is a chondroitin sulfate proteoglycan that in humans is encoded by the CSPG4 gene.
Gene data
CSPG4- Name
- chondroitin sulfate proteoglycan 4
- Type
- protein-coding
- Position
- 75,674,322–75,712,856 (−)
- Aliases
- CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2
- Ensembl
- ENSG00000173546
- RefSeq RNA
- NM_001897.5, XM_047432196.1, XM_054377370.1
- RefSeq protein
- NP_001888.2, XP_047288152.1, XP_054233345.1
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008].
Gene Ontology
Biological process
Molecular function
Pathways
via MyGene.info
Gene · Ensembl
chondroitin sulfate proteoglycan 4
- Symbol
- CSPG4
- Biotype
- Protein coding
- Organism
- Homo sapiens
- Location
- 15:75,674,322-75,712,856
- Strand
- Reverse (−)
- Assembly
- GRCh38
via Ensembl · EMBL-EBI
~2 min read
Encyclopedic overview
6 sectionsContents
- Function
- Implications in disease
- See also
- References
- Further reading
- External links
Chondroitin sulfate proteoglycan 4, also known as melanoma-associated chondroitin sulfate proteoglycan (MCSP) or neuron-glial antigen 2 (NG2), is a chondroitin sulfate proteoglycan that in humans is encoded by the CSPG4 gene.
== Function == CSPG4 plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. It represents an integral membrane chondroitin sulfate proteoglycan expressed by human melanoma cells.
Excerpted from Wikipedia’s “CSPG4” article, available under the CC BY-SA 4.0 licence.